Actos — Cancer

Research has suggested that long-term use of Actos may be associated with a higher risk of developing bladder cancer.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more highlights of prescribing information - Takeda ACTOS CANCER

In 2011, the FDA issued a safety communication warning about these risks. Around the same time, countries like France and Germany suspended or restricted the use of the drug. Research has suggested that long-term use of Actos

Because of allegations that the manufacturer failed to adequately warn patients and doctors about the cancer risks, thousands of lawsuits were filed. thousands of lawsuits were filed.